Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus

References

• Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012; 379:2477-88. http://doi.org/10.1016/S0140-6736(11)61849-7. PMID:22549046
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128. http://doi.org/10.1016/S0140-6736(12)61728-0. PMID:23245604
   PubMed Web of Science ®Google Scholar
• Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention. World J Hepatol. 2011;3:285-91. http://doi.org/10.4254/wjh.v3.i12.285. PMID:22216368
   PubMedGoogle Scholar
• Hakim MS, Wang W, Bramer WM, Geng J, Huang F, de Man RA, Peppelenbosch MP, Pan Q. The global burden of hepatitis E outbreaks: A systematic review. Liver Int. 2017;37:19-31. http://doi.org/10.1111/liv.13237. PMID:27542764
   PubMed Web of Science ®Google Scholar
• Kamar N, Mallet V, Izopet J. Ribavirin for chronic hepatitis E virus infection. N Engl J Med. 2014;370:2447-8. http://doi.org/10.1056/NEJMoa1215246. PMID:24941183
   PubMedGoogle Scholar
• Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology. 2012;142:1388-97 e1. http://doi.org/10.1053/j.gastro.2012.02.014. PMID:22537448
   PubMed Web of Science ®Google Scholar
• Takahashi K, Toyota J, Karino Y, Kang JH, Maekubo H, Abe N, Mishiro S. Estimation of the mutation rate of hepatitis E virus based on a set of closely related 7.5-year-apart isolates from Sapporo, Japan. Hepatol Res. 2004;29:212-5. http://doi.org/10.1016/j.hepres.2004.04.004. PMID:15288013
   PubMedGoogle Scholar
• Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, Dubois M, Rostaing L, Izopet J. Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. J Infect Dis. 2014;209:300-3. http://doi.org/10.1093/infdis/jit438. PMID:23964111
   PubMed Web of Science ®Google Scholar
• van Tong H, Hoan NX, Wang B, Wedemeyer H, Bock CT, Velavan TP. Hepatitis E virus mutations: Functional and clinical relevance. EBioMedicine. 2016;11:31-42. http://doi.org/10.1016/j.ebiom.2016.07.039. PMID:27528267
   PubMed Web of Science ®Google Scholar
• Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol. 2007;13:1770-87. http://doi.org/10.3748/wjg.v13.i12.1770. PMID:17465466
   PubMedGoogle Scholar
• Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP, Sinigaglia F, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol. 1999;17:555-61. http://doi.org/10.1038/9858. PMID:10385319
   PubMed Web of Science ®Google Scholar
• Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, Wheeler DK, Gabbard JL, Hix D, Sette A, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2015;43:D405-12. http://doi.org/10.1093/nar/gku938. PMID:25300482
   PubMed Web of Science ®Google Scholar
• Lavigne R, Seto D, Mahadevan P, Ackermann HW, Kropinski AM. Unifying classical and molecular taxonomic classification: Analysis of the Podoviridae using BLASTP-based tools. Res Microbiol. 2008;159:406-14. http://doi.org/10.1016/j.resmic.2008.03.005. PMID:18555669
   PubMed Web of Science ®Google Scholar
• Gu Y, Tang X, Zhang X, Song C, Zheng M, Wang K, Zhang J, Ng MH, Hew CL, Li S, et al. Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res. 2015;25:604-20. http://doi.org/10.1038/cr.2015.34. PMID:25793314
   PubMed Web of Science ®Google Scholar
• Doytchinova IA, Flower DR. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4. http://doi.org/10.1186/1471-2105-8-4. PMID:17207271
   PubMed Web of Science ®Google Scholar
• Debing Y, Ramiere C, Dallmeier K, Piorkowski G, Trabaud MA, Lebosse F, Scholtès C, Roche M, Legras-Lachuer C, de Lamballerie X, et al. Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity. J Hepatol. 2016;65:499-508. http://doi.org/10.1016/j.jhep.2016.05.002. PMID:27174035
   PubMed Web of Science ®Google Scholar
• Debing Y, Gisa A, Dallmeier K, Pischke S, Bremer B, Manns M, Wedemeyer H, Suneetha PV, Neyts J. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology. 2014;147:1008-11 e7. quiz e15-6. http://doi.org/10.1053/j.gastro.2014.08.040. PMID:25181691
   PubMed Web of Science ®Google Scholar
• Todt D, Walter S, Brown RJ, Steinmann E. Mutagenic effects of ribavirin on hepatitis E virus-viral extinction versus selection of fitness-enhancing mutations. Viruses. 2016; 8(10): 283-297. http://doi.org/10.3390/v8100283. PMID:27754363.
   PubMedGoogle Scholar
• Liang JH, Dai X, Dong C, Meng JH. A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus. Int J Mol Sci. 2010;11:2962-75. http://doi.org/10.3390/ijms11082962. PMID:21152284
   PubMed Web of Science ®Google Scholar
• Liang J-H, Dai X, Dong C, Meng J-H. A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus. Int J Mol Sci. 2010;11:2962-75. http://doi.org/10.3390/ijms11082962. PMID:21152284
   PubMed Web of Science ®Google Scholar
• Lhomme S, Kamar N, Nicot F, Ducos J, Bismuth M, Garrigue V, Petitjean-Lecherbonnier J, Ollivier I, Alessandri-Gradt E, Goria O, et al. Mutation in the hepatitis E virus polymerase and outcome of ribavirin therapy. Antimicrob Agents Chemother. 2016;60:1608-14. http://doi.org/10.1128/AAC.02496-15.
   Web of Science ®Google Scholar
• Kamar N, Wang W, Dalton HR, Pan Q. Direct-acting antiviral therapy for hepatitis E virus? Lancet Gastroenterol Hepatol. 2017;2:154-5. http://doi.org/10.1016/S2468-1253(16)30242-4. PMID:28404127
   PubMedGoogle Scholar
• Zhang H, Dai X, Shan X, Meng J. The Leu477 and Leu613 of ORF2-encoded protein are critical in forming neutralization antigenic epitope of hepatitis E virus genotype 4. Cell Mol Immunol. 2008;5:447-56. http://doi.org/10.1038/cmi.2008.56. PMID:19118511
   PubMed Web of Science ®Google Scholar
• Brown A, Halliday JS, Swadling L, Madden RG, Bendall R, Hunter JG, Maggs J, Simmonds P, Smith DB, Vine L, et al. Characterization of the specificity, functionality, and durability of host T-Cell responses against the full-length hepatitis E virus. Hepatology. 2016;64:1934-50. http://doi.org/10.1002/hep.28819. PMID:27631819
   PubMed Web of Science ®Google Scholar
• Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank. Nucleic Acids Res. 2013;41:D36-42. http://doi.org/10.1093/nar/gks1195. PMID:23193287.
   PubMed Web of Science ®Google Scholar
• Choi Y, Chan AP. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745-7. http://doi.org/10.1093/bioinformatics/btv195. PMID:25851949
   PubMed Web of Science ®Google Scholar
• Bao L, Zhou M, Cui Y. nsSNPAnalyzer: Identifying disease-associated nonsynonymous single nucleotide polymorphisms. Nucleic Acids Res. 2005;33:W480-W2. http://doi.org/10.1093/nar/gki372. PMID:15980516
   PubMed Web of Science ®Google Scholar
• Ferrer-Costa C, Gelpí JL, Zamakola L, Parraga I, De La Cruz X, Orozco M. PMUT: A web-based tool for the annotation of pathological mutations on proteins. Bioinformatics. 2005;21:3176-8. http://doi.org/10.1093/bioinformatics/bti486. PMID:15879453
   PubMed Web of Science ®Google Scholar
• Pires DE, Ascher DB, Blundell TL. DUET: A server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res. 2014;42:W314-9. http://doi.org/10.1093/nar/gku411. PMID:24829462
   PubMed Web of Science ®Google Scholar
• Capriotti E, Fariselli P, Casadio R. I-Mutant2. 0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33:W306-W10. http://doi.org/10.1093/nar/gki375. PMID:15980478
   PubMed Web of Science ®Google Scholar
• Quan L, Lv Q, Zhang Y. STRUM: Structure-based prediction of protein stability changes upon single-point mutation. Bioinformatics. 2016;32:2936-46. http://doi.org/10.1093/bioinformatics/btw361. PMID:27318206
   PubMed Web of Science ®Google Scholar
• Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res. 2010;38:D854-62. http://doi.org/10.1093/nar/gkp1004. PMID:19906713
   PubMed Web of Science ®Google Scholar
• Singh H, Raghava GP. ProPred: Prediction of HLA-DR binding sites. Bioinformatics. 2001;17:1236-7. http://doi.org/10.1093/bioinformatics/17.12.1236. PMID:11751237
   PubMed Web of Science ®Google Scholar
• Singh H, Raghava GP. ProPred1: Prediction of promiscuous MHC Class-I binding sites. Bioinformatics. 2003;19:1009-14. http://doi.org/10.1093/bioinformatics/btg108. PMID:12761064
   PubMed Web of Science ®Google Scholar
• Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, Lundegaard C, Sette A, Lund O, Bourne PE, et al. Immune epitope database analysis resource. Nucleic Acids Res. 2012;40:W525-30. http://doi.org/10.1093/nar/gks438. PMID:22610854
   PubMed Web of Science ®Google Scholar